{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-075865","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2025-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.094903+00:00","generated_at":"2026-05-20T22:44:36.374510+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nasdaq panel grants conditional continued listing for Longevity Health pending merger with 20/20 Biolabs by Sept 2, 2025","bullets":["Nasdaq Hearings Panel granted continued listing condition: complete merger with 20/20 Biolabs and meet initial listing rules by Sept 2, 2025.","Company filed S-4 for merger on May 8, 2025, and effected 1-for-30 reverse stock split on May 12, 2025.","Panel based decision on review of financial statements and pro forma projections of combined company.","Chairman/CEO Rajiv Shukla stated focus on completing merger to satisfy Nasdaq requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-075865","json":"https://secwatch.observer/filing/0000950170-25-075865.json","markdown":"https://secwatch.observer/filing/0000950170-25-075865.md","text":"https://secwatch.observer/filing/0000950170-25-075865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025075865/0000950170-25-075865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025075865/xage-20250520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T22:44:36.374510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}